{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:47:41Z","timestamp":1791967661538,"version":"4.3.4"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"German Centre for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is a major modifiable risk factor for atrial fibrillation (AF) and has been linked to processes involved in atrial structural and electrical remodelling. Glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular events in patients with type 2 diabetes at high cardiovascular risk and are increasingly regarded as cardiometabolic therapies. Whether these agents modify the trajectory of atrial cardiomyopathy or exert direct antiarrhythmic effects beyond their metabolic actions remains an area of active investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 50-year-old man with obesity (body mass index 34.9\u2005kg\/m2) and persistent AF presented with persistent symptomatic episodes despite four prior pulmonary vein isolation procedures and repeated electrical cardioversions. Rhythm monitoring was performed continuously using a wearable device since 2023, documenting recurrent episodes lasting 8\u201330\u2005h with a modified European Heart Rhythm Association (mEHRA) class IIb\u2013III symptom burden. Echocardiography demonstrated preserved left ventricular systolic function and left atrial enlargement. In January 2026, once-weekly subcutaneous semaglutide was initiated for weight management (0.25\u2005mg\/week with subsequent dose escalation). While a weight reduction of 14\u2005kg was observed within 6 months, AF episodes and symptoms ceased immediately after treatment initiation and have not recurred during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case describes cessation of recurrent AF episodes following initiation of semaglutide in a patient with obesity and prior ablation failure. Potential mechanisms may include cardiometabolic effects as well as direct myocardial effects on sodium and calcium handling that have been described experimentally. Although a causal relationship cannot be established from a single observation, this finding may serve as a hypothesis-generating signal and provide a rationale for prospective studies evaluating cardiometabolic therapies as potential adjuncts in rhythm control strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag727","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:33:42Z","timestamp":1790508822000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiometabolic therapy for rhythm control: a case report of refractory atrial fibrillation resolving after initiation of semaglutide for obesity"],"prefix":"10.1093","volume":"10","author":[{"given":"Frederike Marie","family":"Weitkamp","sequence":"first","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical Center Goettingen , Robert-Koch-Street 40, Goettingen D-37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-8404","authenticated-orcid":false,"given":"Mirela","family":"Vatic","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical Center Goettingen , Robert-Koch-Street 40, Goettingen D-37075 ,","place":["Germany"]},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, University of Goettingen , Rober-Koch-Street 42a, Goettingen D-37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9818-042X","authenticated-orcid":false,"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical Center Goettingen , Robert-Koch-Street 40, Goettingen D-37075 ,","place":["Germany"]},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, University of Goettingen , Rober-Koch-Street 42a, Goettingen D-37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-237X","authenticated-orcid":false,"given":"Constanze","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical Center Goettingen , Robert-Koch-Street 40, Goettingen D-37075 ,","place":["Germany"]},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, University of Goettingen , Rober-Koch-Street 42a, Goettingen D-37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-0025","authenticated-orcid":false,"given":"Felix","family":"Wiedmann","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical Center Goettingen , Robert-Koch-Street 40, Goettingen D-37075 ,","place":["Germany"]},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, University of Goettingen , Rober-Koch-Street 42a, Goettingen D-37075 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026101404003748500_ytag727-B1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026101404003748500_ytag727-B2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/obr.12056","article-title":"Obesity and atrial fibrillation","volume":"14","author":"Abed","year":"2013","journal-title":"Obes Rev"},{"key":"2026101404003748500_ytag727-B3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026101404003748500_ytag727-B4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026101404003748500_ytag727-B5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamacardio.2025.4007","article-title":"Aggressive risk factor reduction study for atrial fibrillation implications for ablation outcomes: the ARREST-AF randomized clinical trial","volume":"10","author":"Pathak","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026101404003748500_ytag727-B6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026101404003748500_ytag727-B7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026101404003748500_ytag727-B8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713100","article-title":"Glucagon-like peptide-1 receptor activation reduces pulmonary vein arrhythmogenesis and regulates calcium homeostasis","volume":"24","author":"Chan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026101404003748500_ytag727-B9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacbts.2023.01.005","article-title":"Glucagon-like peptide-1 protects against atrial fibrillation and atrial remodeling in type 2 diabetic mice","volume":"8","author":"Bohne","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"2026101404003748500_ytag727-B10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.3644","article-title":"Cardioprotective effects of semaglutide on isolated human ventricular myocardium","volume":"27","author":"Krammer","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026101404003748500_ytag727-B11","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14292","article-title":"Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: a systematic review and meta-analysis","volume":"54","author":"Saglietto","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"2026101404003748500_ytag727-B12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.125.014069","article-title":"Effect of semaglutide on atrial arrhythmias recurrence following ablation for atrial fibrillation: a prospective study","volume":"18","author":"Guo","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026101404003748500_ytag727-B13","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag018","article-title":"Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation","volume":"28","author":"Ciconte","year":"2026","journal-title":"Europace"},{"key":"2026101404003748500_ytag727-B14","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2024.08.023","article-title":"Atrial fibrillation and semaglutide effects in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag727\/71431383\/ytag727.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/10\/ytag727\/71431383\/ytag727.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/10\/ytag727\/71431383\/ytag727.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:00:44Z","timestamp":1791964844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag727\/8840832"}},"subtitle":[],"editor":[{"given":"Niklas","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Luis Antonio","family":"Moreno-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Linh","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag727","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,28]]},"article-number":"ytag727"}}